Dana Farber Cancer Center, Harvard University
Dana Farber Cancer Center, Harvard University
Boston, Massachusetts, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Cancer of the Pancreas Screening-5 CAPS5)Study | Colorectal Neoplasms, Hereditary Nonpolyposis, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, DNA repair disease, Digestive System Diseases, Digestive System Neoplasms, Hyperpigmentation, Lynch syndrome, Melanosis, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Peutz-Jeghers syndrome, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, central nervous system malformation, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, hereditary chronic pancreatitis, hereditary disease, hereditary neoplastic syndrome, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, intestinal disorder, lentigo, malignant endocrine neoplasm, malignant pancreatic neoplasm, melanocytic neoplasm, melanocytic nevus, melanoma, cutaneous malignant, susceptibility to, 2, metabolic disease, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, pancreas disorder, pancreatic neoplasm, peripheral nervous system disorder, polyneuropathy, skin disorder, skin pigmentation disorder | Recruiting | Phase 3 | 2025-10-09 | NCT02000089 |